Skip to main content

MoneyWorks4Me

Advanced Enzyme Technologies informs about outcome of board meeting

31 Oct 2026 Evaluate
Advanced Enzyme Technologies has informed that the Board of Directors at its meeting held on October 31, 2026 has approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..